Arcutis Biotherapeutics Market Sentiment

Arcutis Biotherapeutics Inc

ARQTNASDAQ

Trade with Public

$31.81

0.611.96%

마지막 업데이트: Oct 27, 8:37 AM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

실적: Q3 2026 실적이 수 11월 4th에 시장 마감 후 8일 후 후에 발표됩니다.

Arcutis Biotherapeutics Market Sentiment

Market sentiment signals for Arcutis Biotherapeutics (ARQT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 18.4% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

12 analysts

Options Flow (P/C)

—

Avg Consensus PT

$31

-2.3%

Highest Price Target

$48

+49.6%

Cantor Fitzgerald

Lowest Price Target

-75.1%

HC Wainwright & Co.

Short Interest

18.4%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 19, 2026	Guggenheim	Seamus Fernandez—	+37.1%	$38 → $44	Maintained	Buy
Oct 15, 2026	Cantor Fitzgerald	Steve Seedhouse—	+49.6%	$48	Initiate	Overweight
Aug 6, 2026	Morgan Stanley	Vikram Purohit—	+18.4%	$34 → $38	Maintained	Overweight
Aug 6, 2026	Guggenheim	Seamus Fernandez—	+18.4%	$35 → $38	Maintained	Buy
Aug 6, 2026	Needham	Serge Belanger—	+24.6%	$36 → $40	Maintained	Buy
May 7, 2026	Needham	Serge Belanger—	+12.2%	$36 → $36	Maintained	Buy
Mar 2, 2026	Mizuho	Uy Ear—	+9.1%	$37 → $35	Maintained	Outperform
Feb 27, 2026	Guggenheim	Seamus Fernandez—	+9.1%	$34 → $35	Maintained	Buy
Feb 26, 2026	TD Cowen	Tyler Van Buren—	+9.1%	$30 → $35	Maintained	Buy
Feb 26, 2026	HC Wainwright & Co.	Douglas Tsao—	+6.0%	$30 → $34	Maintained	Buy
Feb 26, 2026	Needham	Serge Belanger—	+12.2%	$31 → $36	Maintained	Buy
Jan 26, 2026	Needham	Serge Belanger—	-3.4%	$30 → $31	Maintained	Buy
Nov 28, 2025	Mizuho	Uy Ear—	+15.3%	$32 → $37	Maintained	Outperform
Oct 30, 2025	Goldman Sachs	Richard Law—	-9.6%	$19 → $29	Maintained	Neutral
Oct 28, 2025	Needham	Serge Belanger—	-6.5%	$22 → $30	Maintained	Buy
Aug 7, 2025	Needham	Serge Belanger—	-31.4%	$20 → $22	Maintained	Buy
Jul 25, 2025	Goldman Sachs	Richard Law—	-43.9%	$18	Initiate	Neutral
May 23, 2025	Needham	Serge Belanger—	-37.7%	$20 → $20	Maintained	Buy
Apr 9, 2025	Needham	Serge Belanger—	-37.7%	$20 → $20	Maintained	Buy
Apr 3, 2025	Guggenheim	Seamus Fernandez—	—	—	Maintained	Buy
Apr 3, 2025	HC Wainwright & Co.	Douglas Tsao—	-40.8%	$19 → $19	Maintained	Buy
Apr 3, 2025	Needham	Serge Belanger—	-37.7%	$20 → $20	Maintained	Buy
Mar 11, 2025	Jefferies	Kambiz Yazdi—	-40.8%	$16 → $19	Maintained	Buy
Feb 27, 2025	Goldman Sachs	Jonathan Block—	-53.3%	$13 → $15	Maintained	Neutral
Feb 26, 2025	HC Wainwright & Co.	Douglas Tsao—	-40.8%	$19 → $19	Maintained	Buy